ESKNF yields 181818.18% · PFE yields 6.13%● Live data
📍 ESKNF pulled ahead of the other in Year 1
Combined, ESKNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ESKNF + PFE for your $10,000?
Esken Limited operates in the aviation and renewables businesses in the United Kingdom, Europe, and internationally. It operates through Aviation, Renewables, Investments, and Non-Strategic Infrastructure segments. The Aviation segment engages in the operation of commercial airports and the provision of ground handling services. The Renewables segment is involved in the supply of sustainable biomass for the generation of renewable energy. The Investments segment engages in the logistics services investing, and baggage handling businesses. The Non-Strategic Infrastructure segment is involved in the management, development, and realization of a portfolio of property assets, including Carlisle Lake District Airport. The company was formerly known as Stobart Group Limited and changed its name to Esken Limited in February 2021. Esken Limited was incorporated in 2002 and is based in Saint Peter Port, Guernsey.
Full ESKNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.